Navigation Links
Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed

CHICAGO, June 05, 2007 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute's Philip A. Philip, M.D., Ph.D. F.R.C.P., professor of medicine and oncology, presented the outcome of one of the largest randomized phase III pancreas cancer clinical trials in North America and chaired an education session about the future of pancreatic cancer therapies at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.

The clinical trial, A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine as First-Line Therapy of Patients with Advanced Pancreas Cancer, questioned the benefit of using Cetuximab to target the epidermal growth factor receptor (EGFR) in advanced pancreatic cancer patients.

The EGFR is a protein found on the surface of some cancer cells and to which the epidermal growth factor binds, causing uncontrolled cell division -- a predisposition for cancer. The EGFR is found at abnormally high levels on the surface of most pancreatic cancer cells. This study examined the effectiveness of Cetuximab, an anticancer monoclonal antibody directed to block the EGFR, combined with the standard chemotherapy agent Gemcitabine prescribed for patients with advanced pancreatic cancer.

Over 760 pancreatic cancer patients, throughout the U.S. and Canada, participated in the study which compared outcomes of Gemcitabine coupled with Cetuximab as first-line chemotherapy against single-agent Gemcitabine.

"Contrary to previous hypotheses, our study found Cetuximab, along with Gemcitabine, did not offer increased benefits in treating a patient's pancreatic cancer," said Dr. Philip.

Initiated by the Southwest Oncology Group, this study was a substantial accomplishment for the group, concluding two years earlier than their initial five-year goal.

"We were able to gather definitive answers in a shorter amount of time, al
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:11/21/2014)... 21, 2014   Rock Creek Pharmaceuticals, Inc., ... is scheduled to present at the Biotech Showcase™ 2015 ... on January 12-14, 2015. ... Rock Creek Pharmaceuticals, will present preclinical and clinical data ... exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan will outline the ...
(Date:11/21/2014)... 21. November 2014 ... bekannt gegeben, dass die Europäische Arzneimittel-Agentur ... Kennzeichnung als Orphan-Medizinprodukt an Palovarotene vergeben ... zur Behandlung von Fibrodysplasia ossificans progressiva ... beeinträchtigende genetische Krankheit, die von schmerzhaften, ...
(Date:11/21/2014)... 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) ... Officer, will be presenting at the 26 th Annual ... in New York . The formal presentation ... ET. In addition, Mr. Krakauer and Jorgen B. Hansen ... meetings during the day. An audio webcast ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... ATLANTA, May 25, 2011 XDATA retains Adapt ... patents and fully-functioning prototype focused on breast cancer ... and tested methods and devices for automatically capturing ... validation of the value of XDATA,s patents, leading ...
... as a sort of Huffington Post for the Medical ... offering "Your One Source For Growing Medical Marijuana" for ... worldwide. This first of its kind web ... growing Medical Marijuana and the lifestyle that has arisen ...
Cached Medicine Technology:XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System 2
(Date:11/21/2014)... Mo (PRWEB) November 21, 2014 ... the Get With The Guidelines®–Heart Failure Gold-Plus Quality ... outlined by the American Heart Association/American College of ... heart failure patients. , Get With The Guidelines–Heart ... hospital teams provide the most up-to-date, research-based guidelines ...
(Date:11/21/2014)... VA (PRWEB) November 21, 2014 Launched ... App (ECA) is an all-in-one senior care coordination tool ... on loved ones simple and intuitive for family members ... day care centers). Now, the family caregiver or home ... their daily activities, health data, medical records, goals, schedules, ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer in ... accessories. Furthermore, the company has launched its Special Black Friday ... its fashion items. Also, orders above $59 are qualified for ... their wedding dresses and prom dresses are very popular in ... , The CEO says “We are glad to introduce ...
(Date:11/21/2014)... 2014 CARE Surrogacy Center in Mexico ... — and at the same time enhancing their surrogacy journey ... for future parents across the globe, the company is reporting ... today are zoning in on the skyrocketing costs of surrogacy ... are individuals over-stressing clinical success rates ? , ...
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... world’s only ISO verified healthcare professional panel, today announced two ... the appointment of Roni DasGupta as President of Market Research, ... of Market Research, Europe. , Ms. DasGupta joined ... Vice President and most recently Head of Sales. Roni ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... pneumonia and gastrointestinal woes , , THURSDAY, Oct. 30 (HealthDay ... age 65 and older resulted in medical and lost ... researchers who analyzed Medicare and National Health Interview Survey ... study were: chronic lung disease, ischemic heart disease, stroke, ...
... 30 Palomar Medical,Technologies, Inc. (Nasdaq: PMTI ... for cosmetic treatments, today announced financial,results for the ... the,quarter ended September 30, 2008 were $24.2 million, ... were royalty revenues, $1.0 million,were funded development revenues, ...
... to Eat Right, Move More and ... Milk Their Diets, ATLANTA, Oct. ... different fad diets -- which seem to go in and out of,fashion like ... Americans -- including 56 percent of Georgia,residents -- remain overweight or obese., ...
... Oct. 30 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... novel anti-infective products, is scheduled,to announce its financial ... Nov. 13, 2008, before the market opens. At ... conduct a conference call to review the,Company,s third ...
... Ariz., Oct. 30 NaturalNews.com, the independent,natural ... million health-conscious,consumers, has posted audio interviews with ... "Home Safe Home," and Byron Richards, founder ... supplement,provider. Both interviews are available as free ...
... attack rates change when clocks are adjusted , , WEDNESDAY, Oct. ... is just about here, and it may pose problems more ... a jump in the number of heart attacks following the ... spring. , "This was the very first study on this ...
Cached Medicine News:Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 2Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 3Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 4Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 5Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 6Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 7Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 8Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 9Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4Health News:MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results 2Health News:NaturalNews Posts Audio Interview with Consumer Chemical Expert Debra Lynn Dadd on Bisphenol-A 2Health News:Semi-Annual Time Changes May Affect the Heart 2Health News:Semi-Annual Time Changes May Affect the Heart 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: